Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesions

被引：15
|
作者：
Cesinaro, AM
Natoli, C
Grassadonia, A
Tinari, N
Iacobelli, S
Trentini, GP
机构：
[1] Univ Modena & Reggio Emilia, Sect Pathol Anat, Dept Morphol Sci & Legal Med, Modena, Italy
[2] Univ G DAnnunzio, Dept Oncol & Neurosci, Chieti, Italy
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2002年 / 119卷 / 01期
关键词：
D O I：
10.1046/j.1523-1747.2002.17642.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：187 / 190
页数：4
相关论文
共 50 条
  • [1] THE SECRETED TUMOR-ASSOCIATED ANTIGEN 90K IS A POTENT IMMUNE STIMULATOR
    ULLRICH, A
    SURES, I
    DEGIDIO, M
    JALLAL, B
    POWELL, TJ
    HERBST, R
    DREPS, A
    AZAM, M
    RUBINSTEIN, M
    NATOLI, C
    SHAWVER, LK
    SCHLESSINGER, J
    IACOBELLI, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (28) : 18401 - 18407
  • [2] Expression of the proliferation and apoptosis-associated CAS protein in benign and malignant cutaneous melanocytic lesions
    Böni, R
    Wellmann, A
    Man, YG
    Hofbauer, G
    Brinkmann, U
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1999, 21 (02) : 125 - 128
  • [3] c-kit expression in benign and malignant melanocytic lesions: Protein loss with melanoma tumor progression
    Montone, KT
    Belle, P
    Elder, DE
    LABORATORY INVESTIGATION, 1996, 74 (01) : 240 - 240
  • [4] Tumor-associated antigen 90K/Mac-2-binding protein:: Possible role in colon cancer
    Ulmer, Tricia A.
    Keeler, Vicki
    Loh, Lambert
    Chibbar, Rajni
    Torlakovic, Emina
    Andre, Sabine
    Gabius, Hans-Joachim
    Laferte, Suzanne
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 98 (05) : 1351 - 1366
  • [5] Tumor-associated antigen 90K activates myelomonocytic cell line THP-1
    Altindag, ZZ
    Marth, C
    WernerFelmayer, G
    Natoli, C
    Zeimet, AG
    Wachter, H
    Iacobelli, S
    Fuchs, D
    CANCER LETTERS, 1996, 107 (01) : 143 - 148
  • [6] THE 90K TUMOR-ASSOCIATED ANTIGEN AND CLINICAL PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    IACOBELLI, S
    ULLRICH, A
    TINARI, N
    ORTONA, L
    TAMBURRINI, E
    DEGIDIO, M
    GHINELLI, F
    SIGHINOLFI, L
    PIAZZA, M
    CHIRIANNI, A
    GUERRA, L
    NATOLI, C
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1995, 10 (04) : 450 - 456
  • [7] Expression of Oncostatin M in benign and malignant melanocytic lesions.
    Jones, DM
    Mu, XC
    Tran, TA
    Ross, JS
    Carlson, JA
    LABORATORY INVESTIGATION, 1999, 79 (01) : 58A - 58A
  • [8] Novel genes associated with malignant melanoma but not benign melanocytic lesions
    Talantov, D
    Mazumder, A
    Yu, JX
    Briggs, T
    Jiang, YQ
    Backus, J
    Atkins, D
    Wang, YX
    CLINICAL CANCER RESEARCH, 2005, 11 (20) : 7234 - 7242
  • [9] Overexpression and elevated plasma level of tumor-associated antigen 90K/Mac-2 binding protein in colorectal carcinoma
    Wu, Chih-Ching
    Huang, Yu-Shan
    Lee, Li-Yu
    Liang, Ying
    Tang, Rei-Ping
    Chang, Yu-Sun
    Hsieh, Ling-Ling
    Yu, Jau-Song
    PROTEOMICS CLINICAL APPLICATIONS, 2008, 2 (12) : 1586 - 1595
  • [10] Tumor-stroma interaction in benign and malignant melanocytic skin lesions
    FinkPuches, R
    Smolle, J
    HofmannWellenhof, R
    Woltsche, I
    Kerl, H
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (03) : 68 - 68
12345